Tracheobronchial Tuberculosis
Conditions
Interventions
Bronchoscopy interventional group:Bronchoscopic interventional therapy
Simple drug group:Anti-tuberculosis drug treatment
Sponsors
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with tracheobronchial tuberculosis between the ages of 16 and 65 years; 2. Be conscious and fluent in speech, with compliance to the treatment; 3. Give voluntary, signed informed consent in accordance with institutional policies.
Exclusion criteria
Exclusion criteria: 1. Irreversible contraindications of bronchoscopic examinations; 2. Asymptomatic inactive tuberculosis; 3. Comorbidities of the cardiovascular, liver, renal and hematopoietic system, psychiatric disorders and other other medical, psychosocial, or emotional conditions that adversely affect life quality; 4. Currently participation in other interventional clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of tracheal stenosis;Lung function test;mMRC;6-minute walking distance;Bronchoscopic findings;Chest CT scan; | — |
Countries
China
Contacts
Public ContactShuliang Guo
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed